Furthermore, these lymphomas exhibit a congruent mutational spectrum, notably featuring loss-of-function mutations in genes associated with methylation, such as TET2, identified in approximately 80% of instances, and DNMT3A, observed in 30–40% of cases. This evidence concerns the gene TET2 and lymphoma.